Live: Will Constellation Brands Smash Q1 Earnings After the Bell Tonight?

Investing

Merck : MRK

All Merck Articles

1083 Articles

Paul Ausick | Mar 21, 2014 at 4:01 PM EDT

The 5 Stocks That Sank Markets on Friday

thinkstockMarch 21, 2014: Markets opened higher on Friday but the Nasdaq sank quickly, bounced for a while, and finally settled…

Jon C. Ogg | Mar 21, 2014 at 10:30 AM EDT

Did Endocyte Just Become Buyout Bait?

Endocyte is trading like it is being acquired. This is proof that any biotech with great cancer drug news can…

Douglas A. McIntyre | Mar 21, 2014 at 6:38 AM EDT

Ten Huge Companies Dodged State Taxes for Five Years

States, often burdened by budget deficits that grew during the recession, are not getting tax receipts from some of America's…

Paul Ausick | Mar 12, 2014 at 11:20 AM EDT

Short Interest Generally Wanes in High-Yield Dividend Stocks

ThinkstockThe short interest data for the final two weeks of February is out, and the results are somewhat surprising when…

Trey Thoelcke | Mar 12, 2014 at 9:00 AM EDT

Low P/E High-Dividend Blue Chip Leaders to Buy Now

The pricier the stock market gets, the more important it is for investors to keep a close eye on what…

Trey Thoelcke | Mar 10, 2014 at 9:05 AM EDT

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the…

Trey Thoelcke | Feb 17, 2014 at 7:05 AM EST

Biotech Buyout Bolsters Novartis Cancer Portfolio

Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not…

Paul Ausick | Feb 5, 2014 at 8:20 AM EST

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to…

Jon C. Ogg | Feb 4, 2014 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 4, 2014.…

Paul Ausick | Feb 3, 2014 at 7:15 AM EST

Only Four Dow Stocks Post January Gains

The 30 stocks comprising the Dow Jones Industrial Average combined to post a loss of just over 4.5% in January.…

Paul Ausick | Jan 27, 2014 at 4:15 PM EST

The 5 Stocks That Dominated the Market on Monday

thinkstockJanuary 27, 2014: Markets opened slightly higher on Monday and equities spent the day bouncing around the breakeven line. Tech…

Jon C. Ogg | Jan 25, 2014 at 8:03 AM EST

Five Big Stocks That Escaped the Market Carnage Sell-Off

The stock market was pounded on Friday, making for a very bad week and a rough start for January. Still,…

Jon C. Ogg | Jan 22, 2014 at 4:04 PM EST

5 Stocks That Dominated The Market Wednesday

ThinkstockWednesday was yet another mixed day in the stock market, one where the Dow Jones Industrial Average was in the…

Jon C. Ogg | Jan 13, 2014 at 4:05 PM EST

5 Stocks That Led The Market on Monday

Jon OggThe markets had only a small employment report from the Conference Board to consider on Monday, as well as…

Jon C. Ogg | Jan 11, 2014 at 8:01 AM EST

The 2014 DJIA Bull and Bear Case: Boeing, Verizon, Coke, JPMorgan, Pfizer and More

Jon OggWe are now well past the end of 2013, and many strategists have mixed targets for the stock and…

1 … 49 50 51 52 53 … 73

Merck : MRK

All Merck Articles

The 5 Stocks That Sank Markets on Friday

Did Endocyte Just Become Buyout Bait?

Ten Huge Companies Dodged State Taxes for Five Years

Short Interest Generally Wanes in High-Yield Dividend Stocks

Low P/E High-Dividend Blue Chip Leaders to Buy Now

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Biotech Buyout Bolsters Novartis Cancer Portfolio

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

Only Four Dow Stocks Post January Gains

The 5 Stocks That Dominated the Market on Monday

Five Big Stocks That Escaped the Market Carnage Sell-Off

5 Stocks That Dominated The Market Wednesday

5 Stocks That Led The Market on Monday

The 2014 DJIA Bull and Bear Case: Boeing, Verizon, Coke, JPMorgan, Pfizer and More

Live: Will Constellation Brands Smash Q1 Earnings After the Bell Tonight?

Live: Will Nike Crush Q4 Earnings and Continue Their Turnaround Tonight?

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

You’re 30 with Little Saved, but $500 a Month in These 3 ETFs Might Make You a Millionaire

AI Isn’t Killing Jobs. New Study Finds Companies That Use AI Most Are Leading a Hiring Boom.

Her Husband Handled the Medicare Paperwork. After He Died, Her Premium Doubled Overnight.

A 66-Year-Old With $1.1 Million in Her IRA Owes the IRS More Than She Thinks

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

You’re 30 with Little Saved, but $500 a Month in These 3 ETFs Might Make You a Millionaire

Merck : MRK

All Merck Articles

The 5 Stocks That Sank Markets on Friday

Did Endocyte Just Become Buyout Bait?

Ten Huge Companies Dodged State Taxes for Five Years

Short Interest Generally Wanes in High-Yield Dividend Stocks

Low P/E High-Dividend Blue Chip Leaders to Buy Now

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Biotech Buyout Bolsters Novartis Cancer Portfolio

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

Only Four Dow Stocks Post January Gains

The 5 Stocks That Dominated the Market on Monday

Five Big Stocks That Escaped the Market Carnage Sell-Off

5 Stocks That Dominated The Market Wednesday

5 Stocks That Led The Market on Monday

The 2014 DJIA Bull and Bear Case: Boeing, Verizon, Coke, JPMorgan, Pfizer and More

Live: Will Constellation Brands Smash Q1 Earnings After the Bell Tonight?

Live: Will Nike Crush Q4 Earnings and Continue Their Turnaround Tonight?

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

You’re 30 with Little Saved, but $500 a Month in These 3 ETFs Might Make You a Millionaire

AI Isn’t Killing Jobs. New Study Finds Companies That Use AI Most Are Leading a Hiring Boom.

Featured Reads

Her Husband Handled the Medicare Paperwork. After He Died, Her Premium Doubled Overnight.

A 66-Year-Old With $1.1 Million in Her IRA Owes the IRS More Than She Thinks